Seizert Capital Partners, LLC Johnson & Johnson Transaction History

Seizert Capital Partners, LLC

$2.16 Billion
Q3 2024

A detailed history of Seizert Capital Partners, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Seizert Capital Partners, LLC holds 244,057 shares of JNJ stock, worth $35.3 Million. This represents 1.83% of its overall portfolio holdings.

Number of Shares

244,057

Previous 241,616 1.01%

Holding current value

$35.3 Million

Previous $35.3 Million 12.0%

% of portfolio

1.83%

Previous 1.8%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$145.48 - $167.38 $355,116 - $408,574	2,441 Added 1.01%	244,057 $39.6 Million
Q2 2024 Aug 07, 2024	SELL	$144.38 - $157.78 $1.71 Million - $1.87 Million	-11,839 Reduced 4.67%	241,616 $35.3 Million
Q1 2024 May 01, 2024	BUY	$155.22 - $162.74 $485,062 - $508,562	3,125 Added 1.25%	253,455 $40.1 Million
Q4 2023 Feb 07, 2024	SELL	$145.6 - $158.88 $1.69 Million - $1.85 Million	-11,632 Reduced 4.44%	250,330 $39.2 Million
Q3 2023 Nov 06, 2023	BUY	$155.75 - $174.48 $4.51 Million - $5.05 Million	28,926 Added 12.41%	261,962 $40.8 Million
Q2 2023 Jul 27, 2023	SELL	$154.35 - $166.11 $206,365 - $222,089	-1,337 Reduced 0.57%	233,036 $38.6 Million
Q1 2023 May 09, 2023	SELL	$151.05 - $180.26 $2.71 Million - $3.23 Million	-17,944 Reduced 7.11%	234,373 $36.3 Million
Q4 2022 Jan 30, 2023	SELL	$160.2 - $179.79 $741,726 - $832,427	-4,630 Reduced 1.8%	252,317 $44.6 Million
Q3 2022 Nov 02, 2022	SELL	$161.33 - $179.52 $901,834 - $1 Million	-5,590 Reduced 2.13%	256,947 $42 Million
Q2 2022 Aug 04, 2022	BUY	$168.19 - $186.01 $553,681 - $612,344	3,292 Added 1.27%	262,537 $46.6 Million
Q1 2022 May 03, 2022	SELL	$158.14 - $179.59 $557,443 - $633,054	-3,525 Reduced 1.34%	259,245 $45.9 Million
Q4 2021 Feb 08, 2022	SELL	$155.93 - $173.01 $691,861 - $767,645	-4,437 Reduced 1.66%	262,770 $45 Million
Q3 2021 Nov 03, 2021	BUY	$161.5 - $179.47 $2.76 Million - $3.07 Million	17,090 Added 6.83%	267,207 $43.2 Million
Q2 2021 Aug 05, 2021	BUY	$159.48 - $171.07 $3.68 Million - $3.95 Million	23,073 Added 10.16%	250,117 $41.2 Million
Q1 2021 May 05, 2021	SELL	$153.07 - $170.48 $371,347 - $413,584	-2,426 Reduced 1.06%	227,044 $37.3 Million
Q4 2020 Feb 08, 2021	SELL	$137.11 - $157.38 $1.77 Million - $2.03 Million	-12,892 Reduced 5.32%	229,470 $36.1 Million
Q3 2020 Nov 03, 2020	SELL	$140.38 - $153.83 $2 Million - $2.19 Million	-14,224 Reduced 5.54%	242,362 $36.1 Million
Q2 2020 Aug 06, 2020	SELL	$128.81 - $155.51 $2.59 Million - $3.12 Million	-20,075 Reduced 7.26%	256,586 $36.1 Million
Q1 2020 May 05, 2020	SELL	$111.14 - $153.99 $5.73 Million - $7.94 Million	-51,531 Reduced 15.7%	276,661 $36.3 Million
Q4 2019 Feb 10, 2020	BUY	$127.5 - $146.44 $2.49 Million - $2.86 Million	19,535 Added 6.33%	328,192 $47.9 Million
Q3 2019 Nov 07, 2019	SELL	$126.95 - $142.14 $1.19 Million - $1.33 Million	-9,381 Reduced 2.95%	308,657 $39.9 Million
Q2 2019 Aug 06, 2019	SELL	$131.15 - $144.24 $3.26 Million - $3.58 Million	-24,842 Reduced 7.25%	318,038 $44.3 Million
Q1 2019 May 07, 2019	BUY	$125.72 - $139.79 $3.41 Million - $3.79 Million	27,130 Added 8.59%	342,880 $47.9 Million
Q4 2018 Feb 08, 2019	BUY	$122.84 - $147.84 $2.74 Million - $3.3 Million	22,308 Added 7.6%	315,750 $40.7 Million
Q3 2018 Nov 09, 2018	BUY	$121.58 - $142.88 $1.13 Million - $1.33 Million	9,295 Added 3.27%	293,442 $40.5 Million
Q1 2018 May 10, 2018	SELL	$125.1 - $148.14 $277,847 - $329,018	-2,221 Reduced 0.78%	284,147 $36.4 Million
Q4 2017 Feb 12, 2018	BUY	$131.22 - $143.62 $271,494 - $297,149	2,069 Added 0.73%	286,368 $40 Million
Q3 2017 Oct 31, 2017	SELL	$129.47 - $135.38 $3.16 Million - $3.3 Million	-24,404 Reduced 7.91%	284,299 $37 Million
Q2 2017 Aug 09, 2017	BUY	N/A	308,703	308,703 $40.8 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $378B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seizert Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seizert Capital Partners, LLC with notifications on news.

Account

Seizert Capital Partners, LLC Johnson & Johnson Transaction History